http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 23 Jul 2026 08:35:03 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Downgrades/Jefferies+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26805268.html <p>Jefferies analyst Matthew Stanton downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Hold with a price target of $31.00 (from $30.00).</p> <p>For an analyst ratings summary and ratings history on BioLife Solutions <a href="http://www.streetinsider.com/rating_history.php?q=BLFS">click here</a>. For more ratings news on BioLife Solutions <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BLFS&amp;type=analyst">click here</a>.</p> <p>Shares of BioLife Solutions closed at $31.15 yesterday.</p> http://www.streetinsider.com/Downgrades/Jefferies+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26805268.html Thu, 23 Jul 2026 08:35:03 -0400 BLFS http://www.streetinsider.com/Analyst+PT+Change/Jefferies+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26805268.html <p>Jefferies analyst Matthew Stanton downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Hold with a price target of $31.00 (from $30.00).</p> <p>For an analyst ratings summary and ratings history on BioLife Solutions <a href="http://www.streetinsider.com/rating_history.php?q=BLFS">click here</a>. For more ratings news on BioLife Solutions <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BLFS&amp;type=analyst">click here</a>.</p> <p>Shares of BioLife Solutions closed at $31.15 yesterday.</p> http://www.streetinsider.com/Analyst+PT+Change/Jefferies+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26805268.html Thu, 23 Jul 2026 08:35:03 -0400 BLFS http://www.streetinsider.com/Downgrades/H.C.+Wainwright+Downgrades+BioLife+Solutions+%28BLFS%29+to+Neutral/26803951.html <p>H.C. Wainwright analyst Yi Chen downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Neutral with a price target of $31.00 (from $32.00).</p> <p>For an analyst ratings summary and ratings history on BioLife Solutions <a href="http://www.streetinsider.com/rating_history.php?q=BLFS">click here</a>. For more ratings news on BioLife Solutions <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BLFS&amp;type=analyst">click here</a>.</p> <p>Shares of BioLife Solutions closed at $31.15 yesterday.</p> http://www.streetinsider.com/Downgrades/H.C.+Wainwright+Downgrades+BioLife+Solutions+%28BLFS%29+to+Neutral/26803951.html Thu, 23 Jul 2026 06:08:48 -0400 BLFS http://www.streetinsider.com/Analyst+PT+Change/H.C.+Wainwright+Downgrades+BioLife+Solutions+%28BLFS%29+to+Neutral/26803951.html <p>H.C. Wainwright analyst Yi Chen downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Neutral with a price target of $31.00 (from $32.00).</p> <p>For an analyst ratings summary and ratings history on BioLife Solutions <a href="http://www.streetinsider.com/rating_history.php?q=BLFS">click here</a>. For more ratings news on BioLife Solutions <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BLFS&amp;type=analyst">click here</a>.</p> <p>Shares of BioLife Solutions closed at $31.15 yesterday.</p> http://www.streetinsider.com/Analyst+PT+Change/H.C.+Wainwright+Downgrades+BioLife+Solutions+%28BLFS%29+to+Neutral/26803951.html Thu, 23 Jul 2026 06:08:48 -0400 BLFS http://www.streetinsider.com/Downgrades/TD+Cowen+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26803139.html <p>TD Cowen analyst Brendan Smith downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Hold with a price target of $31.00 (from $33.00).</p><p>The analyst comments: “We are downgrading BioLife Solutions to Hold from Buy and lowering our price target to $31 (~11x our FY27 revenue estimates) from $33 following this morning's announcement confirming Repligen's plan to acquire the company for $31/share (~2:1 equity:cash transaction). We remain constructive on the underlying business, though the announced transaction largely captures the near-term value creation opportunity we saw in the standalone story and shifts the investment case toward deal completion rather than business execution.”</p><p>For an http://www.streetinsider.com/Downgrades/TD+Cowen+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26803139.html Thu, 23 Jul 2026 01:04:57 -0400 BLFS http://www.streetinsider.com/Analyst+Comments/TD+Cowen+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26803139.html <p>TD Cowen analyst Brendan Smith downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Hold with a price target of $31.00 (from $33.00).</p><p>The analyst comments: “We are downgrading BioLife Solutions to Hold from Buy and lowering our price target to $31 (~11x our FY27 revenue estimates) from $33 following this morning's announcement confirming Repligen's plan to acquire the company for $31/share (~2:1 equity:cash transaction). We remain constructive on the underlying business, though the announced transaction largely captures the near-term value creation opportunity we saw in the standalone story and shifts the investment case toward deal completion rather than business execution.”</p><p>For an http://www.streetinsider.com/Analyst+Comments/TD+Cowen+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26803139.html Thu, 23 Jul 2026 01:04:57 -0400 BLFS http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIOLIFE+SOLUTIONS+INC+++++For%3A+Jul+21/26802694.html si-local-file:///var/storage/secattach/20260722/26802694.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIOLIFE+SOLUTIONS+INC+++++For%3A+Jul+21/26802694.html Wed, 22 Jul 2026 17:18:00 -0400 BLFS O.06009992 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIOLIFE+SOLUTIONS+INC+++++For%3A+Jul+21/26802694.html si-local-file:///var/storage/secattach/20260722/26802694.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIOLIFE+SOLUTIONS+INC+++++For%3A+Jul+21/26802694.html Wed, 22 Jul 2026 17:18:00 -0400 BLFS O.06009992 http://www.streetinsider.com/SEC+Filings/Form++425++++++++BIOLIFE+SOLUTIONS+INC++++++++++++++++++Filed+by%3A+REPLIGEN+CORP/26801726.html si-local-file:///var/storage/secattach/20260722/26801726.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++BIOLIFE+SOLUTIONS+INC++++++++++++++++++Filed+by%3A+REPLIGEN+CORP/26801726.html Wed, 22 Jul 2026 16:10:00 -0400 BLFS O.06009992 http://www.streetinsider.com/SEC+Filings/Form++425++++++++BIOLIFE+SOLUTIONS+INC++++++++++++++++++Filed+by%3A+REPLIGEN+CORP/26801726.html si-local-file:///var/storage/secattach/20260722/26801726.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++BIOLIFE+SOLUTIONS+INC++++++++++++++++++Filed+by%3A+REPLIGEN+CORP/26801726.html Wed, 22 Jul 2026 16:10:00 -0400 BLFS O.06009992 http://www.streetinsider.com/Downgrades/Craig-Hallum+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26801147.html <p>Craig-Hallum analyst Matt Hewitt downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Hold with a price target of $31.00.</p> <p>For an analyst ratings summary and ratings history on BioLife Solutions <a href="http://www.streetinsider.com/rating_history.php?q=BLFS">click here</a>. For more ratings news on BioLife Solutions <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BLFS&amp;type=analyst">click here</a>.</p> <p>Shares of BioLife Solutions closed at $29.19 yesterday.</p> http://www.streetinsider.com/Downgrades/Craig-Hallum+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26801147.html Wed, 22 Jul 2026 14:55:27 -0400 BLFS http://www.streetinsider.com/Downgrades/Maxim+Group+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26801141.html <p>Maxim Group analyst Jason McCarthy downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Hold.</p> <p>For an analyst ratings summary and ratings history on BioLife Solutions <a href="http://www.streetinsider.com/rating_history.php?q=BLFS">click here</a>. For more ratings news on BioLife Solutions <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BLFS&amp;type=analyst">click here</a>.</p> <p>Shares of BioLife Solutions closed at $29.19 yesterday.</p> http://www.streetinsider.com/Downgrades/Maxim+Group+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26801141.html Wed, 22 Jul 2026 14:54:29 -0400 BLFS http://www.streetinsider.com/Downgrades/Lake+Street+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26799953.html <p>Lake Street analyst Thomas Flaten downgraded BioLife Solutions (NASDAQ: BLFS) from Buy to Hold with a price target of $31.00.</p> <p>For an analyst ratings summary and ratings history on BioLife Solutions <a href="http://www.streetinsider.com/rating_history.php?q=BLFS">click here</a>. For more ratings news on BioLife Solutions <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BLFS&amp;type=analyst">click here</a>.</p> <p>Shares of BioLife Solutions closed at $29.19 yesterday.</p> http://www.streetinsider.com/Downgrades/Lake+Street+Downgrades+BioLife+Solutions+%28BLFS%29+to+Hold/26799953.html Wed, 22 Jul 2026 10:32:52 -0400 BLFS http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html <p>Repligen Corporation (NASDAQ: RGEN) announced it has entered into a definitive agreement to acquire BioLife Solutions, Inc. (NASDAQ: BLFS) for a total enterprise value of approximately $1.5 billion, according to a press release issued July 22, 2026.</p><p>Under the terms of the deal, BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, equating to a total value of $31.00 per share. The consideration is structured as 64% Repligen common stock and 36% cash. The offer represents a 24% premium to BioLife's 90-day volume-weighted average price for the period ended July 21, 2026. The cash http://www.streetinsider.com/Mergers+and+Acquisitions/Repligen+to+acquire+BioLife+Solutions+for+%7E%241.5B/26797406.html Wed, 22 Jul 2026 06:00:41 -0400 A.05786303 A.10371245 A.17839596 A.18787491 A.41697867 A.50205154 BLFS O.00008617 O.00046810 O.00395077 O.00981936 O.06009992 O.13576167 O.35786635 O.51342686 RGEN